Advertisement
Screener

CAREDX, INC. (CDNA) Operating Income

CAREDX, INC. Operating Income

CAREDX, INC. (CDNA) reported Operating Income of $113.22 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-30.

Financial Statements › Income Statement

us-gaap:OperatingIncomeLoss · last filed 2026-07-30

  • CAREDX, INC. operating income (loss) for the quarter ending 2026-06-30 was $113.22M.
  • CAREDX, INC. operating income (loss) for the quarter ending 2026-03-31 was $1.20M.
  • CAREDX, INC. operating income (loss) for the quarter ending 2025-12-31 was -$6.04M, a 107.16% decline year-over-year.
  • CAREDX, INC. operating income (loss) for the quarter ending 2025-09-30 was -$246.00K.
  • CAREDX, INC. operating income (loss) for fiscal 2025 was -$30.78M, a 175.51% decline from fiscal 2024.
  • CAREDX, INC. operating income (loss) for fiscal 2024 was $40.77M.
  • CAREDX, INC. operating income (loss) for fiscal 2023 was -$203.36M.
  • CAREDX, INC. operating income (loss) for fiscal 2022 was -$77.23M.
Period endOperating Income (Loss) 3 monthOperating Income (Loss) 3 month as first filedOperating Income (Loss) 6 monthOperating Income (Loss) 6 month as first filedOperating Income (Loss) 9 monthOperating Income (Loss) 9 month as first filedOperating Income (Loss) 12 month
2026-06-30$113.22M
10-Q · filed 2026-07-30
$114.42M
10-Q · filed 2026-07-30
$108.38M
derived: sum of 3 quarters · filed 2026-07-30
$108.14M
derived: sum of 4 quarters · filed 2026-07-30
2026-03-31$1.20M
10-Q · filed 2026-04-28
-$4.84M
derived: sum of 2 quarters · filed 2026-04-28
-$5.09M
derived: sum of 3 quarters · filed 2026-04-28
-$16.21M
derived: sum of 4 quarters · filed 2026-07-30
2025-12-31-$6.04M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25
-$6.29M
derived: sum of 2 quarters · filed 2026-02-25
-$17.41M
derived: sum of 3 quarters · filed 2026-07-30
-$30.78M
10-K · filed 2026-02-25
2025-09-30-$246.00K
10-Q · filed 2025-11-04
-$11.37M
derived: sum of 2 quarters · filed 2026-07-30
-$24.74M
10-Q · filed 2025-11-04
$59.64M
derived: sum of 4 quarters · filed 2026-07-30
2025-06-30-$11.12M
10-Q · filed 2026-07-30
-$24.50M
10-Q · filed 2026-07-30
$59.88M
derived: sum of 3 quarters · filed 2026-07-30
$46.16M
derived: sum of 4 quarters · filed 2026-07-30
2025-03-31-$13.37M
10-Q · filed 2026-04-28
$71.00M
derived: sum of 2 quarters · filed 2026-04-28
$57.28M
derived: sum of 3 quarters · filed 2026-04-28
$49.96M
derived: sum of 4 quarters · filed 2026-04-28
2024-12-31$84.38M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25
$70.66M
derived: sum of 2 quarters · filed 2026-02-25
$63.33M
derived: sum of 3 quarters · filed 2026-02-25
$40.77M
10-K · filed 2026-02-25
2024-09-30-$13.72M
10-Q · filed 2025-11-04
-$10.49M
10-Q · filed 2024-11-04
-$21.05M
derived: sum of 2 quarters · filed 2025-11-04
-$43.61M
10-Q · filed 2025-11-04
-$33.93M
10-Q · filed 2024-11-04
-$166.25M
derived: sum of 4 quarters · filed 2026-02-25
2024-06-30-$7.33M
10-Q · filed 2025-08-06
-$4.10M
10-Q · filed 2024-07-31
-$29.89M
10-Q · filed 2025-08-06
-$23.43M
10-Q · filed 2024-07-31
-$152.53M
derived: sum of 3 quarters · filed 2026-02-25
-$181.31M
derived: sum of 4 quarters · filed 2026-02-25
2024-03-31-$22.57M
10-Q · filed 2025-04-30
-$19.34M
10-Q · filed 2024-05-09
-$145.20M
derived: sum of 2 quarters · filed 2026-02-25
-$173.98M
derived: sum of 3 quarters · filed 2026-02-25
-$201.60M
derived: sum of 4 quarters · filed 2026-02-25
2023-12-31-$122.63M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25
-$151.41M
derived: sum of 2 quarters · filed 2026-02-25
-$179.04M
derived: sum of 3 quarters · filed 2026-02-25
-$203.36M
10-K · filed 2026-02-25
2023-09-30-$28.78M
10-Q · filed 2024-11-04
-$56.41M
derived: sum of 2 quarters · filed 2024-11-04
-$80.73M
10-Q · filed 2024-11-04
-$99.85M
derived: sum of 4 quarters · filed 2025-02-28
2023-06-30-$27.62M
10-Q · filed 2024-07-31
-$51.95M
10-Q · filed 2024-07-31
-$71.07M
derived: sum of 3 quarters · filed 2025-02-28
-$88.41M
derived: sum of 4 quarters · filed 2025-02-28
2023-03-31-$24.32M
10-Q · filed 2024-05-09
-$43.44M
derived: sum of 2 quarters · filed 2025-02-28
-$60.78M
derived: sum of 3 quarters · filed 2025-02-28
-$82.50M
derived: sum of 4 quarters · filed 2025-02-28
2022-12-31-$19.12M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28
-$36.46M
derived: sum of 2 quarters · filed 2025-02-28
-$58.18M
derived: sum of 3 quarters · filed 2025-02-28
-$77.23M
10-K · filed 2025-02-28
2022-09-30-$17.34M
10-Q · filed 2023-11-08
-$39.06M
derived: sum of 2 quarters · filed 2023-11-08
-$58.11M
10-Q · filed 2023-11-08
-$73.51M
derived: sum of 4 quarters · filed 2024-02-28
2022-06-30-$21.72M
10-Q · filed 2023-08-08
-$40.77M
10-Q · filed 2023-08-08
-$56.17M
derived: sum of 3 quarters · filed 2024-02-28
-$64.90M
derived: sum of 4 quarters · filed 2024-02-28
2022-03-31-$19.05M
10-Q · filed 2023-05-10
-$34.45M
derived: sum of 2 quarters · filed 2024-02-28
-$43.18M
derived: sum of 3 quarters · filed 2024-02-28
-$47.92M
derived: sum of 4 quarters · filed 2024-02-28
2021-12-31-$15.40M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28
-$24.13M
derived: sum of 2 quarters · filed 2024-02-28
-$28.87M
derived: sum of 3 quarters · filed 2024-02-28
-$29.73M
10-K · filed 2024-02-28
2021-09-30-$8.73M
10-Q · filed 2022-11-03
-$13.47M
derived: sum of 2 quarters · filed 2022-11-03
-$14.33M
10-Q · filed 2022-11-03
-$17.39M
derived: sum of 4 quarters · filed 2023-02-27
2021-06-30-$4.74M
10-Q · filed 2022-08-04
-$5.60M
10-Q · filed 2022-08-04
-$8.67M
derived: sum of 3 quarters · filed 2023-02-27
-$11.57M
derived: sum of 4 quarters · filed 2023-02-27
2021-03-31-$858.00K
10-Q · filed 2022-05-05
-$3.92M
derived: sum of 2 quarters · filed 2023-02-27
-$6.83M
derived: sum of 3 quarters · filed 2023-02-27
-$17.64M
derived: sum of 4 quarters · filed 2023-02-27
2020-12-31-$3.07M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-27
-$5.97M
derived: sum of 2 quarters · filed 2023-02-27
-$16.78M
derived: sum of 3 quarters · filed 2023-02-27
-$22.53M
10-K · filed 2023-02-27
2020-09-30-$2.91M
10-Q · filed 2021-10-28
-$13.71M
derived: sum of 2 quarters · filed 2021-10-28
-$19.46M
10-Q · filed 2021-10-28
-$25.01M
derived: sum of 4 quarters · filed 2022-02-24
2020-06-30-$10.80M
10-Q · filed 2021-07-29
-$16.55M
10-Q · filed 2021-07-29
-$22.10M
derived: sum of 3 quarters · filed 2022-02-24
-$28.85M
derived: sum of 4 quarters · filed 2022-02-24
2020-03-31-$5.75M
10-Q · filed 2021-05-05
-$11.30M
derived: sum of 2 quarters · filed 2022-02-24
-$18.04M
derived: sum of 3 quarters · filed 2022-02-24
-$24.89M
derived: sum of 4 quarters · filed 2022-02-24
2019-12-31-$5.54M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24
-$12.29M
derived: sum of 2 quarters · filed 2022-02-24
-$19.14M
derived: sum of 3 quarters · filed 2022-02-24
-$24.53M
10-K · filed 2022-02-24
2019-09-30-$6.75M
10-Q · filed 2020-10-29
-$13.59M
derived: sum of 2 quarters · filed 2020-10-29
-$18.99M
10-Q · filed 2020-10-29
-$21.40M
derived: sum of 4 quarters · filed 2021-02-24
2019-06-30-$6.84M
10-Q · filed 2020-08-04
-$12.24M
10-Q · filed 2020-08-04
-$14.65M
derived: sum of 3 quarters · filed 2021-02-24
-$17.37M
derived: sum of 4 quarters · filed 2021-02-24
2019-03-31-$5.40M
10-Q · filed 2020-04-30
-$7.81M
derived: sum of 2 quarters · filed 2021-02-24
-$10.53M
derived: sum of 3 quarters · filed 2021-02-24
-$15.74M
derived: sum of 4 quarters · filed 2021-02-24
2018-12-31-$2.42M
derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-24
-$5.13M
derived: sum of 2 quarters · filed 2021-02-24
-$10.34M
derived: sum of 3 quarters · filed 2021-02-24
-$15.58M
10-K · filed 2021-02-24
2018-09-30-$2.72M
10-Q · filed 2019-10-31
-$7.93M
derived: sum of 2 quarters · filed 2019-10-31
-$13.16M
10-Q · filed 2019-10-31
-$17.45M
derived: sum of 4 quarters · filed 2020-02-28
2018-06-30-$5.21M
10-Q · filed 2019-08-01
-$10.44M
10-Q · filed 2019-08-01
-$14.73M
derived: sum of 3 quarters · filed 2020-02-28
-$18.59M
derived: sum of 4 quarters · filed 2020-02-28
2018-03-31-$5.24M
10-Q · filed 2019-05-08
-$9.52M
derived: sum of 2 quarters · filed 2020-02-28
-$13.39M
derived: sum of 3 quarters · filed 2020-02-28
-$16.98M
derived: sum of 4 quarters · filed 2020-02-28
2017-12-31-$4.29M
derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-28
-$8.15M
derived: sum of 2 quarters · filed 2020-02-28
-$11.75M
derived: sum of 3 quarters · filed 2020-02-28
-$20.29M
10-K · filed 2020-02-28
2017-09-30-$3.86M
10-Q · filed 2018-11-08
-$7.46M
derived: sum of 2 quarters · filed 2018-11-08
-$16.01M
10-Q · filed 2018-11-08
-$34.87M
derived: sum of 4 quarters · filed 2019-03-06
2017-06-30-$3.60M
10-Q · filed 2018-08-09
-$12.14M
10-Q · filed 2018-08-09
-$31.00M
derived: sum of 3 quarters · filed 2019-03-06
-$35.94M
derived: sum of 4 quarters · filed 2019-03-06
2017-03-31-$8.54M
10-Q · filed 2018-05-10
-$27.41M
derived: sum of 2 quarters · filed 2019-03-06
-$32.34M
derived: sum of 3 quarters · filed 2019-03-06
-$39.31M
derived: sum of 4 quarters · filed 2019-03-06
2016-12-31-$18.86M
derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-06
-$23.79M
derived: sum of 2 quarters · filed 2019-03-06
-$30.76M
derived: sum of 3 quarters · filed 2019-03-06
-$37.33M
10-K · filed 2019-03-06
2016-09-30-$4.93M
10-Q · filed 2017-11-09
-$11.90M
derived: sum of 2 quarters · filed 2017-11-09
-$18.47M
10-Q · filed 2017-11-09
-$22.93M
derived: sum of 4 quarters · filed 2018-03-22
2016-06-30-$6.97M
10-Q · filed 2017-08-11
-$13.54M
10-Q · filed 2017-08-11
-$18.00M
derived: sum of 3 quarters · filed 2018-03-22
-$21.19M
derived: sum of 4 quarters · filed 2018-03-22
2016-03-31-$6.57M
10-Q · filed 2017-06-09
-$11.03M
derived: sum of 2 quarters · filed 2018-03-22
-$14.22M
derived: sum of 3 quarters · filed 2018-03-22
-$17.11M
derived: sum of 4 quarters · filed 2018-03-22
2015-12-31-$4.46M
derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-22
-$7.66M
derived: sum of 2 quarters · filed 2018-03-22
-$10.54M
derived: sum of 3 quarters · filed 2018-03-22
-$11.93M
10-K · filed 2018-03-22
2015-09-30-$3.19M
10-Q · filed 2016-11-14
-$6.08M
derived: sum of 2 quarters · filed 2016-11-14
-$7.47M
10-Q · filed 2016-11-14
-$7.04M
derived: sum of 4 quarters · filed 2017-04-21
2015-06-30-$2.89M
10-Q · filed 2016-08-22
-$4.28M
10-Q · filed 2016-08-22
-$3.85M
derived: sum of 3 quarters · filed 2017-04-21
-$2.46M
derived: sum of 4 quarters · filed 2017-04-21
2015-03-31-$1.39M
10-Q · filed 2016-05-16
-$962.00K
derived: sum of 2 quarters · filed 2017-04-21
$431.00K
derived: sum of 3 quarters · filed 2017-04-21
$86.00K
derived: sum of 4 quarters · filed 2017-04-21
2014-12-31$429.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2017-04-21
$1.82M
derived: sum of 2 quarters · filed 2017-04-21
$1.48M
derived: sum of 3 quarters · filed 2017-04-21
$1.25M
10-K · filed 2017-04-21
2014-09-30$1.39M
10-Q · filed 2015-11-13
$1.05M
derived: sum of 2 quarters · filed 2015-11-13
$821.00K
10-Q · filed 2015-11-13
$1.33M
derived: sum of 4 quarters · filed 2016-03-29
2014-06-30-$345.00K
10-Q · filed 2015-08-12
-$572.00K
10-Q · filed 2015-08-12
-$63.00K
derived: sum of 3 quarters · filed 2016-03-29
-$395.00K
derived: sum of 4 quarters · filed 2016-03-29
2014-03-31-$227.00K
10-Q · filed 2015-05-14
$282.00K
derived: sum of 2 quarters · filed 2016-03-29
-$50.00K
derived: sum of 3 quarters · filed 2016-03-29
-$306.00K
derived: sum of 4 quarters · filed 2016-03-29
2013-12-31$509.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-29
$177.00K
derived: sum of 2 quarters · filed 2016-03-29
-$79.00K
derived: sum of 3 quarters · filed 2016-03-29
-$857.00K
10-K · filed 2016-03-29
2013-09-30-$332.00K
10-Q · filed 2014-11-14
-$588.00K
derived: sum of 2 quarters · filed 2014-11-14
-$1.37M
10-Q · filed 2014-11-14
2013-06-30-$256.00K
10-Q · filed 2014-08-28
-$1.03M
10-Q · filed 2014-08-28
2012-12-31-$2.34M
10-K · filed 2015-03-31

Similar stocks

Stock NameCountryMarket CapPE Ratio
Celcuity Inc. (CELC)United States$3.887B-22.62
VERACYTE, INC. (VCYT)United States$3.904B41.21
Fortrea Holdings Inc. (FTRE)United States$1.903B-19.43
Personalis, Inc. (PSNL)United States$1.769B-13.30
CASTLE BIOSCIENCES INC (CSTL)United States$1.074B-37.45
Lumexa Imaging Holdings, Inc. (LMRI)United States$0.951B
GRAIL, Inc. (GRAL)United States$5.591B-7.78
RadNet, Inc. (RDNT)United States$5.611B-229.65
Fulgent Genetics, Inc. (FLGT)United States$0.593B-6.70
BIODESIX INC (BDSX)United States$0.312B